References
- Kern DM, Devore S, Kim J, et al. Mortality, outcomes, and healthcare costs in T2DM patients at risk for cardiovascular disease. Am J Accountable Care 2015;3:55-61. http://www.ajmc.com/journals/ajac/2015/2015-vol3-n1/mortality-outcomes-and-healthcare-costs-in-t2dm-patients-at-risk-for-cardiovascular-disease. Accessed July 13, 2016
- Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States; 2014. http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf. Accessed July 1, 2016
- Centers for Disease Control and Prevention. Diabetes public health resource. Number (in millions) of civilian, non-institutionalized adults with diagnosed diabetes, United States, 1980–2014. December 1, 2015. http://www.cdc.gov/diabetes/statistics/prev/national/figadults.htm. Accessed July 1, 2016
- American Diabetes Association. Cardiovascular disease and risk management. Diabetes Care 2016;39(suppl1):S60-S71
- Giorda CB, Avogaro A, Maggini M, et al. Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study. Stroke 2007;38:1154-60
- van Dieren S, Beulens JW, Kengne AP, et al. Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review. Heart 2012;98:360-9
- Nichols GA, Brown JB. The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes. Diabetes Care 2002;25:482-6
- Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation 2012;125:e2-e220
- Preis SR, Hwang SJ, Coady S, et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 2009;119:1728-35
- Zhuo X, Zhang P, Hoerger TJ. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. Am J Prev Med 2013;45:253-61
- Johnston SS, Sheehan JJ, Shah M, et al. Cardiovascular event costs in patients with type 2 diabetes mellitus. J Med Econ 2015;18:1032-40
- Straka RJ, Liu LZ, Girase PS, et al. Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting. Cardiovasc Diabetol 2009:8:53
- Li R, Bilik D, Brown MB, et al. Medical costs associated with type 2 diabetes complications and comorbidities. Am J Manag Care 2013;19:421-30
- Gandra SR, Lawrence LW, Parasuraman BM, et al. Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease. J Manag Care Pharm 2006;12:546-54
- Pelletier EM, Smith PJ, Boye KS, et al. Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research. Appl Health Econ Health Policy 2008;6:103-12
- Boyle JP, Thompson TJ, Gregg EW, et al. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 2010;8:29
- Dall TM, Zhang Y, Chen YJ, et al. The economic burden of diabetes. Health Aff (Millwood) 2010;29:297-303
- Li R, Zhang P, Barker LE, et al. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care 2010;33:1872-94
- Ali MK, Bullard KM, Saaddine JB, et al. Achievement of goals in U.S. diabetes care, 1999–2010. N Engl J Med 2013;368:1613-24 [Erratum, N Engl J Med 2013;369:587]
- Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med 2014;370:1514-23
- Ward A, Alvarez P, Vo L, et al. Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012). J Med Econ 2014;17:176-83
- Asche CV, Hippler SE, Eurich DT. Review of models used in economic analyses of new oral treatments for type 2 diabetes mellitus. Pharmacoeconomics 2014;32:15-27
- Wong ND, Zhao Y, Patel R, et al. Cardiovascular risk factor targets and cardiovascular disease event risk in diabetes: a pooling project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study. Diabetes Care 2016;39:668-76